Member Description Overlay
Capital Markets

SVB Leerink is a clear market leader in partnering with innovative healthcare and life sciences companies to raise capital and position them for success in the public markets. Since 2013, we have bookrun 249 public equity transactions raising over $29 billion in proceeds; procuring capital vital to the research and commercialization efforts of our corporate clients while simultaneously delivering strong returns for our investor clients.

The capital formation process offers many different avenues for companies seeking to access leading investors and raise growth capital. Our team is expert across the full spectrum of equity products including Initial Public Offerings, Publicly Marketed Follow-on Offerings, Confidentially Marketed Follow-on Offerings, Registered Directs, and Convertible Debt Offerings.

For select high quality companies seeking to attract top tier public investors but do not desire to conduct a traditional underwritten public offering, SVB Leerink also specializes in structuring and executing late stage private placements, alternative Form 10 go-public, and PIPE transactions. Since 2011, we have raised $3.5 billion for leading healthcare and life sciences companies through these types of transactions. Our professionals leverage their deep healthcare knowledge, relationships with leading public healthcare investors, and transaction experience to customize and execute private financing strategies for our clients. Learn more about our Corporate Access capabilities.